Activated GLS increased glutaminolysis and upregulated mitochondrial function in prostate cancer cells.[29] In our study, we demonstrated that SUCLG2 knockout led to mitochondrial dysfunction through an increase in the succinylation of mitochondrial proteins and inhibited the function of key metabolic enzymes. The gene discussed is GLS; the disease is prostate cancer.